BACKGROUND:Low back pain (LBP) is responsible for more than 2.5 million visits to U.S. emergency departments (EDs) annually. Nearly 30% of patients who present to an ED with acute LBP report functional impairment or pain 3 months later. These patients are at risk of chronic LBP, a highly debilitating condition. In this study, we assessed whether three variables assessable shortly after symptom onset could independently predict poor 3-month outcomes among LBP patients who present to an ED. METHODS: This was a planned analysis of data from two randomized comparative effectiveness studies of patients with acute, nontraumatic, nonradicular LBP. Patients were enrolled during an ED visit, contacted by telephone 1 week after the ED visit, and then followed up by telephone 3 months later. The coprimary 3-month outcomes were LBP-related functional impairment and persistent moderate or severe LBP. Two of the three hypothesized predictor variables were assessed during the index visit: 1) the STarT Back Screening Tool score, a nine-item, multidimensional tool validated and widely used in the outpatient setting, and 2) the patient's own anticipated duration of LBP. The third hypothesized predictor was presence of pain assessed by phone 1 week after the ED visit. We then determined whether these three predictor variables were independently associated with poor outcomes at 3 months, after controlling for medication received, age, and sex. RESULTS: A total of 354 patients were enrolled. Of these, 309 (87%) provided 3-month impairment data and 311 (88%) provided 3-month pain data. At 3 months, 122 of 309 (39%) patients reported functional impairment and 51 of 311(16%) patients reported moderate or severe LBP. Among the three hypothesized predictor variables, 58 of 352 (16%) patients with available data reported a moderate or high STarT Back Screening Tool score, 35 of 321 (11%) patients with available data reported anticipated duration of LBP > 1 week, and 235 of 346 (68%) patients reported pain at 1-week telephone follow-up. After age, sex, and medication received were controlled for in a multivariable logistic regression model, only pain at 1 week was independently associated with 3-month impairment (odds ratio [OR] = 2.42, 95% CI = 1.39-4.22) and 3-month moderate or severe pain (OR = 3.83, 95% CI = 1.53-9.58). CONCLUSIONS: More than one-third of patients reported functional impairment 3 months after an ED visit for acute, nontraumatic, nonradicular LBP. Moderate or severe LBP was less common, reported in about half as many patients (16%). Of the three hypothesized predictor variables, only persistent pain at 1 week was independently associated with poor outcomes at 3 months. Despite its important role in the outpatient setting, the STarT Back Tool was not associated with poor outcomes in this ED cohort.
RCT Entities:
BACKGROUND:Low back pain (LBP) is responsible for more than 2.5 million visits to U.S. emergency departments (EDs) annually. Nearly 30% of patients who present to an ED with acute LBP report functional impairment or pain 3 months later. These patients are at risk of chronic LBP, a highly debilitating condition. In this study, we assessed whether three variables assessable shortly after symptom onset could independently predict poor 3-month outcomes among LBP patients who present to an ED. METHODS: This was a planned analysis of data from two randomized comparative effectiveness studies of patients with acute, nontraumatic, nonradicular LBP. Patients were enrolled during an ED visit, contacted by telephone 1 week after the ED visit, and then followed up by telephone 3 months later. The coprimary 3-month outcomes were LBP-related functional impairment and persistent moderate or severe LBP. Two of the three hypothesized predictor variables were assessed during the index visit: 1) the STarT Back Screening Tool score, a nine-item, multidimensional tool validated and widely used in the outpatient setting, and 2) the patient's own anticipated duration of LBP. The third hypothesized predictor was presence of pain assessed by phone 1 week after the ED visit. We then determined whether these three predictor variables were independently associated with poor outcomes at 3 months, after controlling for medication received, age, and sex. RESULTS: A total of 354 patients were enrolled. Of these, 309 (87%) provided 3-month impairment data and 311 (88%) provided 3-month pain data. At 3 months, 122 of 309 (39%) patients reported functional impairment and 51 of 311(16%) patients reported moderate or severe LBP. Among the three hypothesized predictor variables, 58 of 352 (16%) patients with available data reported a moderate or high STarT Back Screening Tool score, 35 of 321 (11%) patients with available data reported anticipated duration of LBP > 1 week, and 235 of 346 (68%) patients reported pain at 1-week telephone follow-up. After age, sex, and medication received were controlled for in a multivariable logistic regression model, only pain at 1 week was independently associated with 3-month impairment (odds ratio [OR] = 2.42, 95% CI = 1.39-4.22) and 3-month moderate or severe pain (OR = 3.83, 95% CI = 1.53-9.58). CONCLUSIONS: More than one-third of patients reported functional impairment 3 months after an ED visit for acute, nontraumatic, nonradicular LBP. Moderate or severe LBP was less common, reported in about half as many patients (16%). Of the three hypothesized predictor variables, only persistent pain at 1 week was independently associated with poor outcomes at 3 months. Despite its important role in the outpatient setting, the STarT Back Tool was not associated with poor outcomes in this ED cohort.
Authors: Benjamin W Friedman; Eddie Irizarry; Clemencia Solorzano; Eleftheria Zias; Scott Pearlman; Andrew Wollowitz; Michael P Jones; Purvi D Shah; E John Gallagher Journal: Ann Emerg Med Date: 2019-04-05 Impact factor: 5.721
Authors: C Treanor; S Brogan; Y Burke; A Curley; J Galvin; L McDonagh; C Murnaghan; P Mc Donnell; N O'Reilly; K Ryan; H P French Journal: Eur Spine J Date: 2022-07-04 Impact factor: 3.134
Authors: Benjamin W Friedman; Lorena Abril; Farnia Naeem; Eddie Irizarry; Andrew Chertoff; Michael McGregor; Polly E Bijur; E John Gallagher Journal: J Emerg Med Date: 2020-09-09 Impact factor: 1.484
Authors: Howard S Kim; Jody D Ciolino; Nicola Lancki; Kyle J Strickland; Daniel Pinto; Christine Stankiewicz; D Mark Courtney; Bruce L Lambert; Danielle M McCarthy Journal: Phys Ther Date: 2021-03-03
Authors: Scott D Tagliaferri; Maia Angelova; Xiaohui Zhao; Patrick J Owen; Clint T Miller; Tim Wilkin; Daniel L Belavy Journal: NPJ Digit Med Date: 2020-07-09
Authors: Stephanie A Eucker; Shawna Foley; Sarah Peskoe; Alexander Gordee; Thomas Risoli; Frances Morales; Steven Z George Journal: Pain Rep Date: 2022-08-17
Authors: Othman Alkassabi; Lennard Voogt; Pamela Andrews; Ahmad Alhowimel; Jo Nijs; Hana Alsobayel Journal: Int J Environ Res Public Health Date: 2022-07-29 Impact factor: 4.614
Authors: Stephanie A Eucker; Oliver Glass; Catherine A Staton; Mitchell R Knisely; Amy O'Regan; Christi De Larco; Michelle Mill; Austin Dixon; Olivia TumSuden; Erica Walker; Juliet C Dalton; Alexander Limkakeng; Ann Miller W Maxwell; Alex Gordee; Maggie Kuchibhatla; Sheinchung Chow Journal: BMJ Open Date: 2022-09-23 Impact factor: 3.006